NVCT Competitors & Alternatives
Compare Nuvectis Pharma Inc with similar stocks in the same industry
Biotechnology
NVCT
Main Stock$12.57
Tradestie Score
60
Market Cap
$154.27M
Analyst Upside
+33.7%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CAPR
Capricor Therapeutics Inc
|
$29.62
|
$357.51M | - | 58 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$16.29
|
$354.45M | - | 54 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$31.57
|
$353.70M | - | 57 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.71
|
$350.98M | - | 51 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.92
|
$341.56M | - | 60 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.41
|
$332.96M | - | 60 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$14.02
|
$308.74M | - | 58 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.74
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$24.38
|
$297.23M | - | 53 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$29.92
|
$293.03M | - | 55 | Compare |
More NVCT Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry